A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy

PLoS ONE

Volumn 13, Issue 2, 2018, Pages

  Hoshino, Junichi ^a,b   Furuichi, Kengo ^c   Yamanouchi, Masayuki ^a   Mise, Koki ^d   Sekine, Akinari ^a   Kawada, Masahiro ^a   Sumida, Keiichi ^a   Hiramatsu, Rikako ^a   Hasegawa, Eiko ^a   Hayami, Noriko ^a   Suwabe, Tatsuya ^a   Sawa, Naoki ^a   Hara, Shigeko ^a   Fujii, Takeshi ^a   Ohashi, Kenichi ^e   Kitagawa, Kiyoki ^f   Toyama, Tadashi ^c   Shimizu, Miho ^c   Takaichi, Kenmei ^a,b   Ubara, Yoshifumi ^a,b   Wada, Takashi ^c,g   more..

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

^c KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

^g KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ALBUMINURIA; ARTERIOSCLEROSIS; ARTICLE; ATROPHY; CALCULATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FIBROSING ALVEOLITIS; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; INFLAMMATION; J SCORE; JAPANESE (PEOPLE); KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; UROGENITAL TRACT DISEASE ASSESSMENT; AGED; JAPAN; MIDDLE AGED; PATHOLOGY;

AGED; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED;

EID: 85041640046     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0190923     Document Type: Article

References (35)

1. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387(10027):1513–30. Epub 2016/04/12. https://doi.org/10.1016/ S0140-6736(16)00618-8 PMID: 27061677.
2. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998; 339(2):69–75. Epub 1998/07/09. https://doi.org/10.1056/NEJM199807093390202 PMID: 9654536.
3. Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, et al. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. Hypertension research: official journal of the Japanese Society of Hypertension. 2008; 31(4):657–64. Epub 2008/07/18. https://doi.org/10.1291/hypres.31.657 PMID: 18633177.
4. Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY, et al. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care. 2013; 36(11):3620–6. Epub 2013/07/10. https://doi.org/10.2337/dc12-2572 PMID: 23835690; PubMed Central PMCID: PMCPMC3816854.
5. Shimizu M, Furuichi K, Yokoyama H, Toyama T, Iwata Y, Sakai N, et al. Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency. Clin Exp Nephrol. 2014; 18(2):305–12. Epub 2013/ 10/02. https://doi.org/10.1007/s10157-013-0870-0 PMID: 24081589.
6. Fioretto P, Mauer M, Brocco E, Velussi M, Frigato F, Muollo B, et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia. 1996; 39(12):1569–76. Epub 1996/12/01. PMID: 8960844.
7. Hong D, Zheng T, Jia-qing S, Jian W, Zhi-hong L, Lei-shi L. Nodular glomerular lesion: a later stage of diabetic nephropathy? Diabetes Res Clin Pract. 2007; 78(2):189–95. Epub 2007/08/09. https://doi.org/10.1016/j.diabres.2007.03.024 PMID: 17683824.
8. Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010; 21(4):556–63. Epub 2010/02/20. doi: ASN.2010010010 [pii] https://doi.org/10.1681/ASN.2010010010 PMID: 20167701.
9. Hoshino J, Mise K, Ueno T, Imafuku A, Kawada M, Sumida K, et al. A Pathological Scoring System to Predict Renal Outcome in Diabetic Nephropathy. Am J Nephrol. 2015; 41(4–5):337–44. Epub 2015/06/ 13. https://doi.org/10.1159/000431333 PMID: 26067713.
10. Mise K, Hoshino J, Ubara Y, Sumida K, Hiramatsu R, Hasegawa E, et al. Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy. Nephrol Dial Transplant. 2014; 29(1):109–18. Epub 2013/10/24. https://doi.org/10.1093/ndt/gft349 PMID: 24151019.
11. Mise K, Hoshino J, Ueno T, Imafuku A, Kawada M, Sumida K, et al. Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy. Diabetic medicine: a journal of the British Diabetic Association. 2015; 32(4):546–55. Epub 2014/11/18. https://doi.org/10.1111/dme.12633PMID: 25400024.
12. Mise K, Hoshino J, Ueno T, Hazue R, Hasegawa J, Sekine A, et al. Prognostic Value of Tubulointersti-tial Lesions, Urinary N-Acetyl-beta-d-Glucosaminidase, and Urinary beta2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy. Clin J Am Soc Nephrol. 2016. Epub 2016/01/24. https://doi.org/10.2215/cjn.04980515 PMID: 26801478.
13. Advani A, Gilbert RE. The endothelium in diabetic nephropathy. Seminars in nephrology. 2012; 32 (2):199–207. Epub 2012/05/24. https://doi.org/10.1016/j.semnephrol.2012.02.006 PMID: 22617769.
14. Morita T, Yamamoto T, Churg J. Mesangiolysis: an update. Am J Kidney Dis. 1998; 31(4):559–73. Epub 1998/04/08. https://doi.org/10.1053/ajkd.1998.v31.pm9531171 PMID: 9531171.
15. Min W, Yamanaka N. Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virchows Archiv A, Pathological anatomy and histopathology. 1993; 423(3):201–7. Epub 1993/01/01. PMID: 8236814.
16. Nyumura I, Honda K, Tanabe K, Teraoka S, Iwamoto Y. Early histologic lesions and risk factors for recurrence of diabetic kidney disease after kidney transplantation. Transplantation. 2012; 94(6):612–9. Epub 2012/09/25. https://doi.org/10.1097/TP.0b013e31825e4a5f PMID: 23001327.
17. Furuichi K, Yuzawa Y, Shimizu M, Hara A, Toyama T, Kitamura H, et al. Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes. Nephrol Dial Transplant. 2017. Epub 2017/03/ 25. https://doi.org/10.1093/ndt/gfw417 PMID: 28340221.
18. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53(6):982–92. Epub 2009/04/03. https://doi.org/10.1053/j.ajkd.2008.12.034 PMID: 19339088.
19. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Journal of diabetes investigation. 2012; 3(1):39–40. Epub 2012/02/20. https://doi.org/10.1111/j.2040-1124.2012.00207.x PMID: 24843544; PubMed Central PMCID: PMCPMC4014931.
20. Royston P, Sauerbrei W. Bootstrap assessment of the stability of multivariable models. Stata Journal. 2009; 9(4):547–70.
21. Breiman L. Bagging predictors. Machine Learning. 1996; 24:123–40.
22. Steyerberg EW. Clinical Prediction Models. New York: Springer; 2010.
23. Fioretto P, Barzon I, Mauer M. Is diabetic nephropathy reversible? Diabetes Res Clin Pract. 2014; 104 (3):323–8. Epub 2014/02/12. https://doi.org/10.1016/j.diabres.2014.01.017 PMID: 24513120.
24. Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria. Nephrology (Carlton). 2012; 17(1):68–75. Epub 2011/09/22. https://doi.org/10.1111/j.1440-1797.2011.01525.x PMID: 21933307.
25. Shimizu M, Furuichi K, Toyama T, Kitajima S, Hara A, Kitagawa K, et al. Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Diabetes Care. 2013; 36 (11):3655–62. Epub 2013/10/04. https://doi.org/10.2337/dc13-0298 PMID: 24089538; PubMed Central PMCID: PMCPmc3816871.
26. An Y, Xu F, Le W, Ge Y, Zhou M, Chen H, et al. Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant. 2014. Epub 2014/07/27. https://doi.org/10.1093/ndt/gfu250 PMID: 25063425.
27. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007; 49(2 Suppl 2):S12–154. Epub 2007/02/06. https://doi.org/10.1053/j.ajkd.2006.12.005 PMID: 17276798.
28. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. Jama. 2016; 315(2):164–74. Epub 2016/01/13. https://doi.org/10.1001/jama.2015.18202 PMID: 26757465.
29. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. Jama. 2011; 305(15):1553–9. Epub 2011/04/13. https://doi.org/10.1001/jama.2011.451 PMID: 21482743.
30. Wolf G, Ritz E. Diabetic nephropathy in type 2 diabetes prevention and patient management. J Am Soc Nephrol. 2003; 14(5):1396–405. Epub 2003/04/23. PMID: 12707409.
31. Yokoyama H, Araki S, Honjo J, Okizaki S, Yamada D, Shudo R, et al. Association between remission of macroalbuminuria and preservation of renal function in patients with type 2 diabetes with overt proteinuria. Diabetes Care. 2013; 36(10):3227–33. Epub 2013/06/20. https://doi.org/10.2337/dc13-0281PMID: 23780946; PubMed Central PMCID: PMCPMC3781501.
32. Araki S, Haneda M, Koya D, Hidaka H, Sugimoto T, Isono M, et al. Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes. Diabetes. 2007; 56(6):1727–30. Epub 2007/03/16. https://doi.org/10.2337/db06-1646 PMID: 17360976.
33. Araki S, Haneda M, Koya D, Sugaya T, Isshiki K, Kume S, et al. Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care. 2013; 36(5):1248–53. Epub 2012/ 12/12. https://doi.org/10.2337/dc12-1298 PubMed Central PMCID: PMCPMC3631864. PMID: 23223350
34. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012; 23(3):507–15. Epub 2012/01/24. https://doi.org/10.1681/ASN.2011060627 PMID: 22266663; PubMed Central PMCID: PMCPMC3294310.
35. Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care. 2005; 28(12):2890–5. Epub 2005/11/25. PMID: 16306550.